Nancy Brown recognized as one of Modern Healthcare’s ‘Top Women Leaders’

American Heart Association CEO awarded prestigious recognition for her work advancing health, equity and hope

2024-03-12

(Press-News.org) DALLAS, March 11, 2024 — Nancy Brown, Chief Executive Officer of the American Heart Association, a global force for healthier lives for all and celebrating one hundred years of lifesaving service, has been recognized by Modern Healthcare as one of the Top Women Leaders for 2024.

The publication’s recognition program acknowledges and honors women executives from all sectors of the healthcare industry for their contributions to care delivery improvement, health equity, policy and gender equity in healthcare leadership.

Since 2008, Brown has served as CEO of the Association, which is celebrating its 100th birthday in 2024. Awardees were selected based on their measurable impact on their company and/or in the healthcare industry during the past 12 months.

“I am deeply honored to receive this recognition from Modern Healthcare and be recognized alongside the rest of the class of 2024 Top Women Leaders. The lifesaving work of the American Heart Association has always been a team effort. The volunteers, supporters, partners, patient, survivors and staff of the American Heart Association power our mission forward – I am humbled to accept this award in recognition of their impact,” says Brown. “I can’t wait to see the impact we will have together in our second century.”

Brown’s recent accomplishments highlight her visionary leadership. In June 2023, the Association launched the “Nation of Lifesavers”, a CPR education movement in response to NFL player Damar Hamlin’s cardiac arrest in January 2023 and the strong interest in the lifesaving technique. The new “Health Care by Food” initiative emphasizes the scientific link between nutrition and well-being. The Association has also been focused on health equity, rural health, food insecurity and other social determinants that affect overall health and well-being. The Association’s strategic successes led to remarkable financial achievements in fiscal year 2022-23, surpassing $1.2 billion in revenue reinforcing its global health leadership position.

As the American Heart Association’s inaugural female CEO, Brown has also been a champion for women and women’s issues, driving global awareness through equitable health movements such as “Go Red for Women®” and “Research Goes Red®”, while also elevating female leaders, volunteers and scientists across all levels of the organization.

“Nancy’s visionary leadership has further strengthened the Association as a global authority on cardiovascular disease and brain health,” said Joseph C. Wu, M.D., Ph.D., FAHA, current volunteer president of the American Heart Association and director of the Stanford Cardiovascular Institute and the Simon H. Stertzer Professor of Medicine and Radiology at Stanford School of Medicine and who nominated her for the award. “Her ability to forge collaborative partnerships across organizations and industries has created a powerful community focused on improving health outcomes. Her compassion, integrity and resilience set a high standard for leadership, leaving a lasting mark on the industry. I look forward to the ways she will continue to shape the healthcare industry and the Association for many years to come.”

The profiles of all honorees are featured in the March 11, 2024 issue of MH magazine and online at ModernHealthcare.com/WLAwards.

###

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for a century. During 2024 - our Centennial year - we celebrate our rich 100-year history and accomplishments. As we forge ahead into our second century of bold discovery and impact our vision is to advance health and hope for everyone, everywhere. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.   

About Modern Healthcare

Modern Healthcare is a trusted business news and information brand in the healthcare industry. Modern Healthcare empowers healthcare leaders and influencers to make timely and informed business decisions. To learn more, go to www.modernhealthcare.com/subscriptions.

END

ELSE PRESS RELEASES FROM THIS DATE:

India's water problems set to get worse as the world warms

2024-03-12

Winter storms that provide crucial snow and rainfall to northern India are arriving significantly later in the year compared to 70 years ago, a new study has found, exacerbating the risk of catastrophic flooding while also reducing vital water supplies for millions of Indians. The cyclonic storms, known as western disturbances, typically bring heavy snow to the Himalayas from December to March. This snowpack slowly melts in spring, providing a steady supply of irrigation water for wheat and other crops downstream. The study, published today (Tuesday, 12 March 2024), in the journal Weather and ...

GPS nanoparticle platform precisely delivers therapeutic payload to cancer cells

2024-03-11

UNIVERSITY PARK, Pa. — A newly developed “GPS nanoparticle” injected intravenously can home in on cancer cells to deliver a genetic punch to the protein implicated in tumor growth and spread, according to researchers from Penn State. They tested their approach in human cell lines and in mice to effectively knock down a cancer-causing gene, reporting that the technique may potentially offer a more precise and effective treatment for notoriously hard-to-treat basal-like breast cancers. They published their work today (March 11) in ACS Nano. They also filed a provisional application to patent the technology ...

New method for triggering and imaging seizures can help guide epilepsy surgery

2024-03-11

Researchers have developed a new method for triggering and imaging seizures in epilepsy patients, offering physicians the ability to collect real-time data to tailor epilepsy surgery. In contrast to previous practice, where physicians from neurology and nuclear medicine had to wait for hours to days in hopes of capturing the onset of a seizure, the new method is convenient, spares resources, and is clinically feasible. This research was published in the March issue of The Journal of Nuclear Medicine. People with epilepsy and seizures who do not respond to medication are often helped by brain surgery. The goal ...

Giving particle detectors a boost

2024-03-11

Device could help facilitate the operation of new particle colliders, such as the Electron-Ion Collider. In particle colliders that reveal the hidden secrets of the tiniest constituents of our universe, minute particles leave behind extremely faint electrical traces when they are generated in enormous collisions. Some detectors in these facilities use superconductivity — a phenomenon in which electricity is carried with zero resistance at low temperatures — to function. For scientists to more accurately observe the behavior of these particles, these weak electrical signals, or currents, need ...

Aging at AACR Annual Meeting 2024

2024-03-11

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Aging is one of the most prominent journals published by Impact Journals. Impact Journals will be participating as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2024 from April 5-10 at the San Diego Convention Center in San Diego, California. This year, the AACR meeting theme is “Inspiring Science • Fueling ...

Oncotarget at AACR Annual Meeting 2024

2024-03-11

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Oncotarget is one of the most prominent journals published by Impact Journals. Impact Journals will be participating as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2024 from April 5-10 at the San Diego Convention Center in San Diego, California. This year, the AACR meeting theme is “Inspiring Science • Fueling Progress • Revolutionizing Care.” Visit booth #4159 at the AACR Annual Meeting 2024 to connect with members of ...

Analysis reveals long-term impact of calcium and vitamin D supplements on health in postmenopausal women

2024-03-11

Embargoed for release until 5:00 p.m. ET on Monday 11 March 2024   Annals of Internal Medicine Tip Sheet    @Annalsofim   Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also ...

Design rules and synthesis of quantum memory candidates

2024-03-11

In the quest to develop quantum computers and networks, there are many components that are fundamentally different than those used today. Like a modern computer, each of these components has different constraints. However, it is currently unclear what materials can be used to construct those components for the transmission and storage of quantum information. In new research published in the Journal of the American Chemical Society, University of Illinois Urbana Champaign materials science & engineering professor Daniel Shoemaker and graduate student Zachary Riedel ...

BIDMC-led trial leads to FDA approval of coronary drug-coated balloons

2024-03-11

BOSTON – In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty. In an original investigation presented at the Cardiology Research Technology conference in Washington, D.C. and published simultaneously in JAMA, the team reports that patients treated with a balloon coated with paclitaxel, a drug to prevent restenosis, experienced lower rates of failure compared with patients treated with an uncoated balloon. The findings of the trial—which ...

This protein pic could help develop new cancer treatments

2024-03-11

Some cancerous tumors hijack proteins that act as “brakes” on our immune system and use them to form a sort of shield against immune recognition. Immunotherapy treatments have been created that turn off these “brakes” and allow our body to attack foreign-looking cancer cells. To further advance such treatments, researchers at Stanford University and New York University have published a new structure of one of these brake proteins, LAG-3. Their work contains key details of the molecule’s structure, as well as information about how the LAG-3 protein functions. Although over a dozen immunotherapies targeting LAG-3 are in development, and one is already FDA approved, ...